New Challenges for International Standard Setting in Biomedicine: CrisprCas, Gene Drives, and How to Target Malaria

Looking at the different fields of biomedicine, it already seems obvious that international standard setting in biomedicine will mean multilayer standard setting by various actors and in various fields of medicine. And it is obvious that in this science and technology-driven area of medicine, the legal rules and private norms face the challenge of adapting to a fast-moving field and even ‘disruptive’ new scientific and technical developments in order to not become outdated and irrelevant. I will elaborate on the problem whether the international order is flexible enough to adapt but can nevertheless give guidance. For this I will give an overview of some of the most relevant rules and norms as well as of some actors.